Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
NIF Ventures is the venture capital and private equity arm of the Daiwa Securities Group. It specializes in early- and later-stage investments. The firm was established in Tokyo in 1982 and has invested in more than 1,560 private companies and assisted more than 460 investees with IPOs. It currently manages approximately $1 billion in funds globally for its shareholders and limited partners.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2003 | Arrow Therapeutics | Series B | 34.9M |
3/2005 | TorreyPines Therapeutics | Series C | 0 |
5/2004 | Plexxikon | Series B | 0 |
7/2003 | Elixent | Series B | 10M |
5/2001 | Netcontinuum | Series B | 26M |
2/2002 | Cyan Technology Ltd | Series B | 2.8M |
1/2002 | On Demand Distribution (OD2) | Venture Round | 5.7M |
9/2000 | HENNGE | Series B | - |
5/2004 | Psytechnics | Series C | 11.6M |
7/2001 | Vpacket Communications | Series C | 40M |
8/2001 | AccessLan Communications | Venture Round | 16M |
4/2003 | Oxxon Therapeutics | Venture Round | 0 |
8/2006 | Psytechnics | Venture Round | - |
3/2005 | Tolerx | Series D | 31M |
9/2002 | SpectraSwitch | Series C | 7.5M |
10/2006 | Tolerx | Series D | 61M |
8/2005 | Intercytex Group | Series D | 0 |
1/2002 | SpectraSwitch | Series B | 6M |
4/2005 | Elixent | Series C | 15M |
9/2003 | Kanisa | Venture Round | 13M |
12/2004 | Escend Technologies | Series D | 3M |
6/2002 | Escend Technologies | Series C | 5.4M |
3/2000 | HENNGE | Series A | - |
1/2004 | Cyclacel Pharmaceuticals | Series D | 38.7M |
9/2000 | Sharing Technologies | Series C | 9M |
10/2000 | Wavesplitter | Venture Round | 51M |
9/1999 | Wavesplitter | Venture Round | 21M |
10/2004 | BioXell | Series C | 29M |
1/2001 | Cyan Technology Ltd | Venture Round | 2M |
7/2000 | eFinance.com | Series A | 0 |
3/2002 | Wavesplitter | Venture Round | 20M |
4/2001 | Antenova | Series A | 4.9M |
7/2000 | Kanisa | Series D | 18M |
8/2001 | Kanisa | Series E | 30M |
10/2003 | Anadigm | Series C | 15M |
2/2001 | HENNGE | Series C | - |
5/2004 | Kleer | Series A | 6M |
5/2002 | SatisFusion | Series C | 1.6M |
1/2000 | Simpata Inc | Series B | 20M |
11/2001 | Accelight Networks | Venture Round | 60M |
10/2006 | Tolerx | Series D | 0 |
8/2006 | Psytechnics | Venture Round | - |
8/2005 | Intercytex Group | Series D | 0 |
4/2005 | Elixent | Series C | 0 |
3/2005 | Tolerx | Series D | 0 |
3/2005 | TorreyPines Therapeutics | Series C | 0 |
12/2004 | Escend Technologies | Series D | 0 |
10/2004 | BioXell | Series C | 0 |
5/2004 | Psytechnics | Series C | 0 |
5/2004 | Plexxikon | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|